Evidence map›Paper›PMID 23911103›Full record

ArticleNeuron2013

Unbiased discovery of glypican as a receptor for LRRTM4 in regulating excitatory synapse development.

Joris de Wit, Matthew L O'Sullivan, Jeffrey N Savas, Giuseppe Condomitti, Max C Caccese, Kristel M Vennekens, John R Yates, Anirvan Ghosh

Open access · bronzeAbstract read
In one paragraph

Article in Neuron, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 92 papers.

0numbers the graph read from it
0cells of the map it votes in
92citing papers in PubMed
6.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

92 citing papers in PubMed, 166 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Cell Adhesion Molecule Signaling at the Synapse: Beyond the Scaffold.Cold Spring Harbor perspectives in biology · 2024
    Review
  19. Article
  20. Article

32 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Joris de WitNeurobiology Section, Division of Biology, University of California San Diego, La Jolla, CA 92093, USA. joris.dewit@cme.vib-kuleuven.be
Matthew L O'Sullivan
Jeffrey N Savas
Giuseppe Condomitti
Max C Caccese
Kristel M Vennekens
John R Yates
Anirvan Ghosh
University of California San Diego · USScripps Research Institute · USVIB-KU Leuven Center for Cancer Biology · BERoche (Switzerland) · CH

Funding

TrainingP41GM103533 · NIGMS · UNIVERSITY OF WASHINGTON · PI MACCOSS, MICHAEL · 2012 to 2021
$20.7M
Quantitative Proteome Analysis of Brain DevelopmentR01MH067880 · NIMH · SCRIPPS RESEARCH INSTITUTE, THE · PI YATES III, JOHN R · 2003 to 2017
$7.1M
Role of AMPA Receptor Reverse Signaling in Synapse StabilityR01NS064124 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GHOSH, ANIRVAN · 2009 to 2012
$1.3M
REGULATION OF GLUTAMATERGIC SYNAPSES BY LEUCINE-RICH REPEAT TRANSMEMBRANE PROTEINR01NS067216 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GHOSH, ANIRVAN · 2010 to 2013
$1.3M
Quantitative Proteomic Approach to Identify the Mechanism of Alzheimer's DiseaseF32AG039127 · NIA · SCRIPPS RESEARCH INSTITUTE, THE · PI SAVAS, JEFFREY NICHOLAS · 2011 to 2014
$117k
European Research Council 311083NIA NIH HHS 1F32AG039127NIA NIH HHS F32 AG039127NIGMS NIH HHS P41 GM103533NIMH NIH HHS R01 MH067880NINDS NIH HHS NS067216NINDS NIH HHS R01 NS064124NINDS NIH HHS R01 NS067216
6 · The paper itself

Abstract

Leucine-rich repeat (LRR) proteins have recently been identified as important regulators of synapse development and function, but for many LRR proteins the ligand-receptor interactions are not known. Here we identify the heparan sulfate (HS) proteoglycan glypican as a receptor for LRRTM4 using an unbiased proteomics-based approach. Glypican binds LRRTM4, but not LRRTM2, in an HS-dependent manner. Glypican 4 (GPC4) and LRRTM4 localize to the pre- and postsynaptic membranes of excitatory synapses, respectively. Consistent with a trans-synaptic interaction, LRRTM4 triggers GPC4 clustering in contacting axons and GPC4 induces clustering of LRRTM4 in contacting dendrites in an HS-dependent manner. LRRTM4 positively regulates excitatory synapse development in cultured neurons and in vivo, and the synaptogenic activity of LRRTM4 requires the presence of HS on the neuronal surface. Our results identify glypican as an LRRTM4 receptor and indicate that a trans-synaptic glypican-LRRTM4 interaction regulates excitatory synapse development.

Indexed as

HippocampusAnimalsAnimals, NewbornEmbryo, MammalianExcitatory Postsynaptic PotentialsFemaleGlypicansHumansIn Vitro TechniquesLuminescent ProteinsMaleMiceMice, TransgenicModels, MolecularNerve Tissue ProteinsNeuronsGlypicansLRRN4 protein, humanLuminescent ProteinsNerve Tissue ProteinsProtein Isoforms

Identifiers

PMID23911103
PMCPMC4003527
OpenAlexW1976786580

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.